Efficacy of alprazolam sublingual tablets in the treatment of the acute phase of panic disorders
{{output}}
Background: Panic disorder affects 2-5% of the general population. In Argentina, one million people would be affected with a 91% rate of psychiatric comorbidity. AIM; To compare efficacy parameters between sublingual (ALP-SL) and... ...
